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The description of itch (formally known as pruritus) as an ‘‘unpleasant sensation that elicits the desire or reflex
to scratch’’ (Ikoma et al., 2006) is immediately familiar. Research in the field of pruritoception has added to our
understanding of this area of sensory neurobiology as it pertains to both normal and pathological conditions.
In particular, much progress has been made on the mechanisms and circuits of itch, which we review here.Introduction
Itch can be acutely generated, but it is also produced clinically by
any number of causes. Pruritoceptive itch occurs through activa-
tion of peripheral nerve fibers (e.g., from insect bites or poison
ivy). Neuropathic itch results from neuronal damage (e.g., shin-
gles), whereas psychogenic itch is of psychiatric origin (e.g.,
obsessive-compulsivedisorder) (Yosipovitch andSamuel, 2008).
Attempts to characterize pruritoception must incorporate no-
ciception as pain is necessary to describe itch comprehensively.
Itch is operationally defined by its requirement for scratching,
a mildly noxious stimulus that inhibits itch sensation. It appears
that itch can be induced by inhibition of pain circuitry as seems
to occur during opioid administration (Szarvas et al., 2003).
Itch or pain can result from different types of stimuli, such as
chemical or mechanical, and the two modalities share certain
cellular and molecular mechanisms. They may also serve similar
protective functions. Nociception often produces an avoidance
response to minimize damage, whereas pruritoception leads to
scratching that can remove irritants like insects from the skin.
However, itch sensation normally occurs well after insect bites
or contact with poison ivy, and thus the unpleasantness of itch
may act as a delayed warning system to avoid future insults.
Several theories have been put forth to explain how itch is de-
tected and the manner in which pain circuitry inhibits and other-
wise overlaps with the itch pathway. Certain components of this
pathway, down to the level of molecules in some cases, have
been identified. We will evaluate the theories and assess their
validity in the context of these results.
At the periphery, a number of recent studies have helped
uncover the molecules and mechanisms involved in itch trans-
duction. This work began with histamine, the most well-charac-
terized pruritogen, and has since been extended to include
a variety of other compounds. Nonhistaminergic forms of itch
have been discovered, leading to a broader understanding of
how itch is detected peripherally. This has also provided addi-
tional targets for therapeutics as numerous medical conditions
involving pruritus are not amenable to antihistamine treatment
(Twycross et al., 2003).
How Is Itch Encoded?
Given that scratching an itch is the most fundamental aspect of
pruritoception, the theories proposed to model itch are defined334 Neuron 68, November 4, 2010 ª2010 Elsevier Inc.by how pain relates to itch. Beginning with intensity theory, put
forth based on experiments from nearly a century ago (von
Frey 1922; Lewis et al., 1927), several theories have been
offered.
Intensity theory requires neurons that are activated by both
painful and itchy stimuli (McMahon and Koltzenburg 1992). As
the name suggests, these cells would discriminate between
the two depending upon the intensity of stimulation produced.
The same neuron could be weakly or strongly activated,
producing the sensation of itch or pain, respectively. However,
later work in humans has made this theory untenable. If intensity
of stimulation is increased, then an itchy sensation should
transition to a painful one, but this was not observed (Tuckett
1982). Similarly, a lower intensity of a painful stimulus does not
turn into itch (Ochoa and Torebjo¨rk 1989; Handwerker et al.,
1991).
Another theory termed labeled line requires separate popula-
tions of neurons for whom detection of itch or pain is mutually
exclusive. Work by Schmelz and colleagues (1997) in humans
identified a promising set of histamine-sensitive C fibers in hu-
mans. This population, consisting of fibers with low conduction
velocities, high activation thresholds, and no sensitivity to
mechanical stimuli, exhibited properties that were noticeably
different from other known nociceptors.
However, the same group (Schmelz et al., 2003) went on to
show that these supposed itch-only fibers were activated by
nociceptive stimuli, notably capsaicin. Johanek and colleagues
(2007) later identified fibers responding to itch induced by
cowhage, but not histamine, and these were also activated by
capsaicin. A recent study from Imamachi et al. (2009) confirms
that seemingly nociceptive neurons are vital for itch detection.
Intrathecal injection of capsaicin to selectively ablate TRPV1+
fibers from the dorsal root ganglia (DRG) led to substantial defi-
cits in the behavioral scratch response to pruritogens. Collec-
tively, these data argue against the labeled linemodel by demon-
strating that purported pruritoceptors also respond to algogens.
The correct model should incorporate neurons that sense both
nociceptive and pruritogenic stimuli but can nonetheless differ-
entiate the two. Peripheral neurons that are candidate prurito-
ceptors often detect painful stimuli as well (Schmelz et al.,
2003; Johanek et al., 2007; Shim et al., 2007; Namer et al.,
2008; Liu et al., 2009). On the other hand, nociceptors that are
Figure 1. The Selectivity Theory of Itch
(A) Diagram of pain versus itch perception according to the selectivity model. Pain sensation is produced upon activation (denoted by stripes) of the larger noci-
ceptive population, which includes many itch-selective neurons. If the smaller itch-selective subset is activated on its own, the lack of inhibition by nociceptors
produces the perception of itch. The nonoverlapping itch neurons could include the unconfirmed itch-specific cells of the labeled line model.
(B) First- and second-order connections in the pain and itch pathways. The illustration shows one potential combination of interactions among primary sensory
neurons, interneurons, and projection neurons that is consistent with the selectivity model but others are possible as well. For example, instead of or in addition to
those from peripheral nociceptors, synaptic contacts may also exist from nociceptive spinal neurons to interneurons. Mast cell release of histamine alone is
depicted for clarity, although other pruritogens, e.g., 5HT, tryptases, and interleukins, are likely to play a role as well. A minus sign indicates the inhibitory synapse
between the interneuron and itch-selective spinal cord neuron.
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seen, suggesting that pruritoceptors may constitute a subset
of the nociceptor population. A form of population-based coding
with sensation produced by activation of a specific array of
neurons (McMahon and Koltzenburg 1992) would fit this
observation.
Itch-responsive neurons within the larger nociceptor popula-
tion may then be considered selective for itch and would
produce this sensation upon activation. However, if a painful
stimulus also activates the larger nociceptive population, this
greater response would mask the itch-responsive subset and
produce the sensation of pain (Figure 1A). In this manner, inhibi-
tion of the itch pathway occurs via the nociceptive-only neurons.
This hypothesis, termed the selectivity model (Handwerker 1992;
McMahon and Koltzenburg 1992; Simone et al., 2004), explains
the commonalities of itch and pain while accounting for their
opposing actions.
The Selectivity Model at the Periphery
Two studies in this issue of Neuron provide supporting
evidence for the selectivity model by identifying a population
of peripheral neurons that appears to include the itch-selectivesubset (Lagerstro¨m et al., 2010; Liu et al., 2010). Liu et al.
endorse a theory they term population coding, which is equiv-
alent to the selectivity theory nomenclature used by Lagerstro¨m
et al. as well as this minireview. The gene for the vesicular
glutamate transporter VGLUT2 was deleted from DRG neurons
with a variety of DRG-specific Cre mouse lines. Variation in Cre
expression can account for some differences in behavioral
phenotypes between the two groups’ mice, and the results
are otherwise similar. As expected, removal of VGLUT2 in
conditional knockout mice impaired glutamatergic signaling in
the targeted nociceptive neurons to produce thermal pain defi-
cits. Strikingly, upon reaching 2 months of age, most mice
had developed skin lesions resulting from spontaneous
scratching. Evoked itch initiated by injection of compound
48/80 or other pruritogens is also elevated when VGLUT2
expression is absent. In addition, it would be worthwhile to
test whether the mice are affected in models of chronic itch,
which could reveal the role of VGLUT2 in clinical itch states.
Compared to the itch phenotype, the pain deficits observed
in these mice are mild. Compensation for the loss of synaptic
input early in development could contribute to these lesser
pain deficits. The partial reduction in the pain response mayNeuron 68, November 4, 2010 ª2010 Elsevier Inc. 335
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a strong itch phenotype.
The studies report a high degree of overlap between the
VGLUT2+ population and gastrin-releasing peptide+ (GRP) and
MrgprA3+ cells, which have previously been characterized as
itch-sensitive neurons (Sun and Chen, 2007; Sun et al., 2009;
Liu et al., 2009). They show that VGLUT2 expression also coin-
cides with a subset of TRPV1+ cells consistent with the
TRPV1+ neuron ablation study described earlier (Imamachi
et al., 2009). Notably, each report demonstrates that both hista-
minergic and nonhistaminergic itch are affected. Further experi-
ments, including ablation of putative itch-selective subpopula-
tions, e.g., MrgprA3+ or GRP+ cells, are needed to firmly
establish a particular requirement for these neurons in itch.
One prediction of the selectivity model (Figure 1) is that acti-
vating the itch-selective subset alone without concomitant acti-
vation of the remaining, nociceptive TRPV1+ cells should
generate itch, even if this is done with an algogen. Liu et al.
(2010) provide indirect evidence for this in an experiment in
which capsaicin is injected into the cheek before the mice
have developed skin lesions. In the VGLUT2-Nav1.8-Cre
knockout mice, i.e., with nociceptors silenced by disrupting
glutamatergic transmission, capsaicin induces itch rather than
pain sensation. Eliminating the ‘‘nociceptor-only’’ population,
i.e., those nociceptors that do not also respond to pruritogens,
could extend these results if capsaicin can induce itch in the
absence of inhibition from the deleted nociceptor population.
Lagerstro¨m et al. (2010) observe a reduction in the itch response
to topical capsaicin application, but this could be due to desen-
sitization of pain and itch fibers 2 hr after capsaicin treatment.
Although most evidence supports the selectivity model at the
DRG level, it is possible that an unidentified subset of DRG
neurons exists that is dedicated to a specific type of itch but
not pain pathway.
Considering the Selectivity Theory of Itch
in the Spinal Cord
The expected central targets for pruritoceptors, a subset of C
fibers, are dorsal horn neurons located in the upper laminae of
the spinal cord. Studies have investigated their potential role
as second-order neurons in the itch circuit.
Simone et al. (2004) saw that mostmonkey spinothalamic tract
(STT) neurons were capsaicin sensitive and a subset of these
also responded to histamine. Work in rat (Jinks and Carstens
2002) found capsaicin also activated dorsal horn neurons re-
sponding to the itch mediator serotonin 5HT. Experiments in
mouse showed that itch-selective spinal neurons, activated by
histamine and 5HT as well as SLIGRL-NH2, an agonist for the
PAR2 receptor, responded to nociceptive stimuli including heat
and mustard oil (Akiyama et al., 2009a, 2009b). The inhibition
of itch by pain was shown in monkey by Davidson et al.
(2007a), who observed that peripheral scratching inhibited hista-
mine- or cowhage-sensitive STT neurons. They later found
a group of histamine- and capsaicin-responsive cells that were
inhibited by scratching upon application of the former but not
latter compound (Davidson et al., 2009). These data from
different animal models suggest the dual activation of neurons
by either itchy or painful stimuli occurs centrally as predicted336 Neuron 68, November 4, 2010 ª2010 Elsevier Inc.by selectivity theory. However, there is still debate about the
applicability of selectivity versus labeled line theory to itch
circuitry in the spinal cord.
In 2001, an STT population responsive to histamine was seen
in cat spinal cord, providing early evidence for a potential itch-
specific population (Andrew and Craig, 2001). Certain STT
neurons responded only to histamine and not mustard oil,
a painful stimulus. The later discovery of a role for the gastrin-
releasing peptide receptor (GRPR) in itch (Sun and Chen,
2007; Sun et al., 2009) may also mark an itch-specific subset.
This receptor is found in the spinal cord dorsal horn, and GRP,
the putative ligand, is expressed in some small-diameter DRG
neurons. Evoked nonhistaminergic itch, but not pain, is signifi-
cantly decreased in GRPR mutant mice. When GRPR+ cells
are ablated, both histaminergic and nonhistaminergic itch
behavior are lost, whereas pain sensitivity is intact. Importantly,
in GRPR-ablated lamina I dorsal horn, NK-1+ neurons, most of
which are STT neurons required for both pain and itch behavior
(see below), are still present, suggesting that GRPR+ and STT
neurons comprise two separate populations. The GRPR+
neurons are candidates for the itch-specific spinal cord neurons
postulated by labeled line theory. Electrophysiological record-
ings of these neurons demonstrating that they respond to itchy
but not painful stimuli are needed to rule out the possibility that
GRPR+ cells play a dispensable role in the pain pathway. It is
also important to determine whether GRPR+ cells are projection
neurons or interneurons.
Another dorsal horn population expresses NK-1, a G protein-
coupled receptor (GPCR) demonstrated to play a critical role in
itch produced by 5HT in rat (Carstens et al., 2010). Removal of
NK-1+ neurons also leads to pain deficits (Mantyh et al., 1997;
Nichols et al., 1999), suggesting this cell population contains
the putative pruritoceptors of the selectivity model while also
contributing to nociception. It will be interesting to see whether
NK-1 overlaps with GRPR in the rat spinal cord and, conversely,
whether NK-1 ablation in mouse matches the rat phenotype.
This also raises the important issue of species differences in
pruritoception. Even rats, the closest model system to mice,
are unique in that histamine does not induce a behavioral scratch
response (Jinks and Carstens 2002). At the level of both DRG
(Johanek et al., 2008; Namer et al., 2008) and spinal cord (David-
son et al., 2007b) in humans and nonhuman primates, there
seem to be separate C fibers for histaminergic and nonhistami-
nergic (namely cowhage-induced) itch. Mice, however, demon-
strate some overlap with respect to activation by these
compounds (Akiyama et al., 2009a, 2009b), highlighting another
important species difference that must be acknowledged.
The role of spinal interneurons has been the subject of limited
study, but a paper from Ross et al. (2010) identifies a subset of
these cells involved in itch. The transcription factor Bhlhb5 is
required for development of some dorsal horn neurons. Ablation
of this gene from an inhibitory interneuron population marked by
Pax2 leads to the development of skin lesions at 2 months of
age in these mice. These results, which parallel those of the
VGLUT2 studies, offer a place for spinal interneurons in the
itch circuit and call for their further investigation.
A preliminary picture of the pain and itch circuitry emerges
from the collective DRG and spinal cord data (Figure 1B). This
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the molecular identity of certain critical neurons in the pathway.
Molecular Mechanisms of Itch Signaling
Historically, humans were the animal model of choice for the itch
field, but this was a limitation with respect to molecular studies.
Rodent models, especially the mouse (Kuraishi et al., 1995), al-
lowed for targeted manipulation of itch-selective neurons and
insight into itch signaling for both histaminergic and nonhistami-
nergic forms of itch.
Primary sensory neurons are responsible for the transduction
of itch induced by pruritogens, which often act directly upon
receptors within these fibers. Another step may be involved if
the pruritogen first activates a nonneuronal cell type, which
then releases pruritogen(s) that will consequently signal through
primary fibers. Both are common means of generating itch, but
the majority of studies have investigated the former to look for
the receptors targeted by particular pruritogens and their
concomitant signaling mechanisms.
The histamine H1 receptor has been considered the main
mediator for itch generated by histamine, although the H4
receptor may also be important (Bell et al., 2004). The H1
receptor couples with phospholipase C b3 (PLCb3) (Han et al.,
2006) and the erstwhile purely nociceptive (Caterina et al.,
2000) ion channel TRPV1 (Shim et al., 2007; Imamachi
et al., 2009). Cowhage is thought to produce a nonhistaminergic
form of itch through PAR2 and/or PAR4 (Reddy et al., 2008), and
both are known to play a role in pain sensation (Ossovskaya and
Bunnett 2004). Other PAR2 agonists including the aforemen-
tioned SLIGRL-NH2 (Shimada et al., 2006) and the protease tryp-
tase (Ui et al., 2006) are demonstrably pruritogenic. Intriguingly,
TRPV1 may also play a role here as PAR2 activation is known to
sensitize TRPV1 (Amadesi et al., 2004; Dai et al., 2004).
5HT acts uponGPCRs of the 5HTR family in the context of itch,
and although this also requires PLCb3, TRPV1 is not involved
(Imamachi et al., 2009). The GPCR MrgprA3 is the target for
another notable pruritogen, chloroquine, a well-known antima-
larial drug that often produces noncompliance from the side
effect of severe pruritus (Liu et al., 2009). Thus, the participation
of GPCRs and TRP channels, which come up repeatedly,
may help guide future studies to elucidate itch transduction
pathways.
Indirect activation of secondary cell types by pruritogens is not
as well characterized. Mast cells are associated with itch (Sugi-
moto et al., 1998) given that they release several pruritogens
(Harvima et al., 2008) upon degranulation, and other cells of
the immune system may also play a role (Ikoma et al., 2006).
Another source is the skin, on which keratinocytes, to take one
example, contain potential itch-related molecules like TRPV3
and TRPV4 (Chung et al., 2004). A TRPV3 mutation has been
linked to allergic and pruritic dermatitis in mice that is thought
to originate from expression in keratinocytes (Yoshioka et al.,
2009).
Although much has been discovered about itch signaling
peripherally, fewer studies have focused on the molecules
involved at the spinal level. GRPR and NK-1 provide starting
points for investigation while other markers and mediators will
uncover molecular pathways for itch in the spinal cord.Neurotransmission in the Itch Circuit
Another critical finding of the two papers from Lagerstro¨m et al.
(2010) and Liu et al. (2010) is that glutamatergic transmission is
not required for signaling in itch-selective neurons. Removal of
the VGLUT2 transporter impairs spontaneous postsynaptic
currents (Liu et al., 2010), although a more thorough character-
ization of the electrophysiological deficits in knockout mice
from both studies is crucial to confirm the loss of glutamatergic
signaling. Although it may still play a modulatory role, direct
transmission with glutamate appears to be dispensable for itch
given that the knockouts show increased itch responses. The
data thus imply another neurotransmitter is required for transmit-
ting the itch signal from the periphery. GRP is an appealing
candidate, although its role must be tested directly.
Spontaneous itch emerges in these studies without pruritic
stimuli present and in which the only functional deficit is impaired
glutamatergic output from sensory afferents. Lagerstro¨m et al.
(2010) found that antihistamines blocked spontaneous itch in
their VGLUT2 mutant mice. Given that exogenous histamine
was not used to induce scratching, it is likely that internal sour-
ces activated the peripheral fibers. This suggests some kind of
input is needed to activate itch-selective neurons in order to
release neurotransmitter and eventually produce an itch percept.
Activation of these fibers by other nonpruritic stimuli could also
generate the sensation of itch in the absence of VGLUT2.
Conclusions
Itch is a recognizable phenomenon in both clinical and nonpa-
thological conditions, and recent work has helped shed light
on the molecular players and circuitry involved in signaling this
important sensory modality. The discovery of afferent fiber pop-
ulations responsive to histamine, the canonical pruritogen, was
later extended to encompass other compounds in the catalog
of pruritogens, which are also capable of generating nonhistami-
nergic forms of itch. After the intensity and labeled line models
initially put forth to explain how itch is encoded, selectivity theory
gained favor after early studies in humans were expanded to
include other primate and mammalian species. The selectivity
model hypothesizes the existence of pruritoceptors that are
part of a larger set of nociceptors in which activation of the whole
group versus that of the itch-selective subset elicits the percep-
tion of pain or itch, respectively.
Deletion of VGLUT2 from certain mouse DRG neuron popula-
tions produces spontaneous itch and enhances both histamin-
ergic and nonhistaminergic varieties of evoked itch. VGLUT2+
cells express molecular markers of previously identified itch-
selective neurons but appear to be part of the larger nociceptor
population (Imamachi et al., 2009; Liu et al., 2009; Shim et al.,
2007; Sun and Chen 2007). Liu et al. (2010) demonstrate that glu-
tamatergic inactivation of nociceptors via removal of VGLUT2
leads to capsaicin-evoked itch instead of pain, providing
evidence for the selectivity theory peripherally. Centrally, the
dorsal horn neurons that follow DRG fibers in the itch pathway
have been identified with molecular and electrophysiological
studies (Jinks and Carstens 2002; Simone et al., 2004; Akiyama
et al., 2009a, 2009b; Davidson et al., 2009; Sun et al., 2009).
These exhibit properties similar to those of the peripheral prurito-
ceptors as predicted by the selectivity model. However, theNeuron 68, November 4, 2010 ª2010 Elsevier Inc. 337
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neurons remains viable. The remarkable molecular diversity of
DRG neurons (Basbaum et al., 2009) means an itch-specific
subpopulation may still be revealed. Labeled line at the spinal
cord level is also possible especially with the striking behavioral
phenotype found in the GRPR+ neuron ablation mice (Sun et al.,
2009).
Experiments to investigate the role of spinal interneurons are
underway and will require further study to characterize what is
likely a crucial part of the itch circuit. The remainder of the circuit,
including central elements such as those in the thalamus and
cortex, has been examined (Drzezga et al., 2001) but how these
regions connect to other parts of the itch pathway has thus far
been the subject of limited study (Craig and Andrew 2002).
An explosion of recent work has shed light on the molecules
and cells involved in the transduction of itchy stimuli. These
studies have identified receptor targets and signaling compo-
nents utilized by a number of pruritogens. Detailed accounts of
these pathways remain to be uncovered along with features
such as how the molecular narratives fit with our understanding
of itch circuitry. This includes specifying how neurotransmission
occurs to signal itch, which has been partially elucidated by
recent work (Lagerstro¨m et al., 2010; Liu et al., 2010) demon-
strating that standard glutamatergic transmission is not
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